Menu
Back to User profile » Dr Suodi Zhai
Papers published by Dr Suodi Zhai:
Empagliflozin in Type 2 Diabetes Mellitus Patients with High Cardiovascular Risk: A Model-Based Cost-Utility Analysis in China
Men P, Liu T, Zhai S
Diabetes, Metabolic Syndrome and Obesity 2020, 13:2823-2831
Published Date: 11 August 2020
A Systematic Review of Vancomycin Dosing in Patients with Hematologic Malignancies or Neutropenia
He N, Dong F, Liu W, Zhai S
Infection and Drug Resistance 2020, 13:1807-1821
Published Date: 16 June 2020
Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles
Yi ZM, Wen C, Cai T, Xu L, Zhong XL, Zhan SY, Zhai SD
Neuropsychiatric Disease and Treatment 2019, 15:1-19
Published Date: 17 December 2018
Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson's disease: systematic review, meta-analysis, and economic evaluation
Yi ZM, Qiu TT, Zhang Y, Liu N, Zhai SD
Therapeutics and Clinical Risk Management 2018, 14:709-719
Published Date: 16 April 2018
Comparison of prophylactic effect of UGIB and effects on platelet function between PPIs and H2RAs combined with DAPT: systematic review and meta-analysis
Yi Z, Qiu T, Zhang Y, Liu Z, Zhai S
Therapeutics and Clinical Risk Management 2017, 13:367-377
Published Date: 24 March 2017
An open-label, two-period comparative study on pharmacokinetics and safety of a combined ethinylestradiol/gestodene transdermal contraceptive patch
Zhang C, Li H, Xiong X, Zhai S, Wei Y, Zhang S, Zhang Y, Xu L, Liu L
Drug Design, Development and Therapy 2017, 11:725-731
Published Date: 10 March 2017
Identify practice gaps in medication education through surveys to patients and physicians
Yi ZM, Zhi XJ, Yang L, Sun SS, Zhang Z, Sun ZM, Zhai SD
Patient Preference and Adherence 2015, 9:1423-1430
Published Date: 9 October 2015